Telehealth & Digital Health

Elixiron's enrupatinib shows promise in targeting neuroinflammation, with early data suggesting cognitive benefits and a new biomarker-guided path for therapy.

For decades, patients with a rare autoimmune anemia faced a cycle of steroids and relapse. New data on a targeted therapy may finally offer a durable solution.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

With a $20M Series A led by L Catterton, Dr. Muneeb Shah's REMEDY is disrupting skincare. Here's how accessible science is winning over consumers.

As youth nicotine pouch use soars, Imperial Tobacco Canada calls for a crackdown on illicit sales. But is this a genuine public health plea or a masterful play to secure its market?

As Ontario doctors adopt AI to fight burnout, a new training program from OntarioMD tackles the urgent medico-legal and privacy risks head-on.

With over 55,000 on waitlists for the UK's first oral weight-loss pill, the market is set to explode. But strict rules and high hopes face a reality check.

Abridge unveils a sweeping AI platform to combat clinician burnout and mend a fragmented system by linking care delivery, payment, and research.

As Seattle welcomes the World Cup, Walgreens is doing more than selling souvenirs. It's a strategic move to capture a transient market with on-demand health services.

As the World Cup descends on Kansas City, Walgreens steps beyond selling snacks, becoming a crucial healthcare lifeline for global fans. Is this the future of event support?

In memory of her daughter Elora, a mother's foundation joins a global research network, turning personal tragedy into a collaborative fight against a rare cancer.

Amedea Pharma's Medical Innovation Olympics isn't just a contest; it's a data-driven crucible for new treatments, with longevity medicine taking center stage.

KPJ Healthcare launches a kidney transplant service, a strategic move addressing a national health crisis and reviving a fifty-year-old medical legacy.

ŌURA's blockbuster deals with football icons Harry Kane and Declan Rice are more than just endorsements; they are a calculated move in the high-stakes wearables war.

With its new 'Edge' plans, the nation's largest customer-owned insurer is using digital tools and psychological 'nudges' to guide patient choices.

Blue Cross and Blue Shield of Texas is betting on a new copay-only plan to cut costs without shrinking networks. Can its 'Easify' platform guide us to a simpler healthcare future?

A new Phoenix clinic is more than an opening; it’s a calculated move in the high-stakes game of fixing America's broken primary care system.

A novel case study reveals how targeted chemotherapy delivery is outsmarting stubborn tumors, highlighting a metabolic victory even when size remains unchanged.

Paradisus La Perla's new WITT certification isn't just an award; it's a strategic move by Meliá to capture the booming $1.3T wellness travel market.

A new FDA-approved therapy from Boehringer Ingelheim and a liquid biopsy from Guardant Health offer the first targeted initial treatment for HER2-mutant NSCLC.